Bozza Patricia T.

Bozza is a senior investigator and head of Laboratory of Immunopharmacology at Oswaldo Cruz Institute, Fundação Oswaldo Cruz (FIOCRUZ), Brazil; she got her MD from the State University of Rio de Janeiro, and her PhD in cellular and molecular biology from the Oswaldo Cruz Institute, Brazil. She received postdoctoral training under Dr. Peter Weller at Harvard Medical School as Pew Latin American Fellow. Bozza is a senior scholar of the Brazilian National Council for Scientific and Technological Development (CNPq) and a member of the Brazilian Academy of Science. She has mentored the work of 24 postdoctoral, 29 PhD and 30 MSc students. Her group's long-term goal is to conduct translational studies that contribute new knowledge on the interplay of metabolic and inflammatory mechanisms in the pathogenesis of emergent and/or severe infectious diseases, aiming at identifying biomarkers and therapeutic targets, including dengue, Zika and COVID-19. In response to the COVID-19 emergency, her group characterized mechanisms involved in thromboinflammation and hypercoagulability in severe COVID-19 patients, and contributed to defining immunometabolic mechanisms involved in infection.